Novel Anti-Ulcer Phytosomal Formulation of Ethanol Extract of Pentaclethra macrophylla Stem-Bark doi.org/10.26538/tjnpr/v4i8.11
Main Article Content
Abstract
Pentaclethra macrophylla, a medicinal plant widely used for ulcer treatment in Nigeria by herbal practitioners, is limited by poor lipid solubility, resulting in poor absorption and bioavailability. Phytosomes, a novel dosage form that are better absorbed and produce better results than conventional herbal extracts, could be employed to enhance its antiulcer activity. The objective of this study was to formulate Pentaclethra macrophylla stem-bark extract as phytosomes by forming complexes with phospholipid and compare the antiulcer activity with omeprazole, a standard anti-ulcer drug. Phytosomal formulations of ethanol extract of Pentaclethra macrophylla stem-bark and Phospholipon® 90G (P90G) (extract:P90G ratios of 1:1, 1:3, 1:5) were prepared following established method. Their physicochemical properties, in vitro drug release in simulated intestinal fluid (SIF, pH=7.4) and simulated gastric fluid (SGF,
pH=1.2) and anti-ulcer properties on aspirin-induced ulcer using Wistar rats were determined and compared with omeprazole. Phytosomes with spherical smooth particles with size range 0.106-0.217 µm and good encapsulation efficiencies (range = 67.61-72.8%) were obtained. Drug release increased with time irrespective of phospholipid concentration or dissolution medium. The extract possessed antiulcer activity (23.33%) which was increased to 33.33, 43.33 and 56.67% by formulating it as phytosomal formulations containing extract:P90G ratios of 1:1, 1:3, 1:5, respectively. However, omeprazole and its formulations gave significantly (p<0.05) greater antiulcer activity when compared with both the ethanol extract and phytosomes. Pentaclethra macrophylla stem-bark possessed antiulcer activity, which was improved via phytosomal formulation. This would serve as potential safer and cheaper alternative therapeutics for ulcer given the side-effects associated with omeprazole.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: Food sources and bioavailability. Am J Clin Nutr. 2004; 79:727–747.
Scalbert A and Williamson G. Dietary intake and bioavailability of Polyphenols. J Nutr. 2000; 130:2073S- 2085S.
Fasinu P, Pillay V, Ndesendo VMK, Choonara E. Diverse approaches for the enhancement of oral drug bioavailability. Biopharm. Drug Dispos 2011; 32(4):185-209.
Venkatesan N, Babu BS, Vyas SP. Protected drug carriers for prolonged systemic circulation-a review. Indiana J Pharm Sci. 2000; 62:327-333.
Rossi R, Basilico F, Rossoni G, Riva A, Morazzoni P, Mauri PL. Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of bilobalide in plasma and brain of rats after oral administration of its phospholipidic complex. J Pharm Biomed Anal. 2009; 50:224–227.
Parris K and Kathleen H. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybinphosphatidylcholine complex. Altern Med N Rev. 2005; 10(3):193-203.
Gupta A, Ashawat MS, Saraf S. Phytosome: A novel approach towards functional cosmetics. J Plant Sci. 2007; 2(6):644-649.
Ravarotto L. Efficacy of silymarin-phospholipid complex in reducing the toxicity of aflatoxin B1 in broiler chicks. Poult Sci. 2004; 83:1839-1843.
Gabetta G, Bombardelli E, Pifferi G. Complexes of flavolignans with phospholipid, preparation thereof and associated pharmaceutical composition. Inverni Della Beffa S.P.A., Milan, Italy. US Patent 4764508, 1998.
Nnamani PO, Kenechukwu FC, Dibua EU, Ogbonna CC, Monemeh UL, Attama AA. Transdermal microgels of gentamicin. Eur J Pharm Biopharm. 2013; 84:345-354.
Attama AA, Reichl S, Müller-Goymann CC. Sustained release and permeation of timolol from surface modified solid lipid nanoparticles through bio-engineered human cornea. Curr Eye Res. 2009; 34(8):698-705.
Attama AA, Reichl S, Müller-Goymann CC. Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm. 2008; 355:307-313.
Imafidon EK and Okunrobo LO. The effects of aqueous extracts of the leaves of Hibiscus rosasinensis Linn on renal function in hypertensive rats. Afr J Biochem Res. 2010; 4(2):043-046.
Akah PA, Aguwa CN, Agu RU. Studies on the antidiarrhoeal properties of Pentaclethra macrophylla. Phytother Res.1999; 13:292-295.
Gill LS. Ethnomedicinal uses of plants in Nigeria. University of Benin press, Nigeria. 1992; 184-185 p.
Keay RWJ, Onochie CEA, Stanfield DP. Nigerian Trees. Department of Forest Research, Ibadan. 2000: 119-120 p.
Okorie CC, Oparaocha ENT, Adewunmi CO, Iwalewa EO, Omodara SK. Antinociceptive, anti-inflammatory and cytotoxic activities of Pentaclethra macrophylla aqueous extracts in mice. Afr J Trad Compl Altern Med. 2006; 3(1):44-53.
Gugnani HC and Ezenwanze EC. Antibacterial activity of extracts of ginger (Zingiber officinale) and African oil bean seed (Pentaclethra macrophylla). J Commun Dis. 2003; 17:233-236.
Ugbogu OC and Akukwe AR. The antimicrobial effect of oils from Pentaclethra macrophylla Bent, Chrysophyllum albidum G. Don and Persea gratissima Gaerth F on some local clinical bacteria isolates. Afr J Biotech. 2009; 8(2):285-287.
Folefoc GN, Bisseck JP, Fomum ZT, Bodo B. Constituents from the roots of Pentaclethra macrophylla. Biochem Syst Ecol. 2005; 33:1280-1282.
Atindehou K, Koné C, Terreaux D, Traore K, Dosso M. Evaluation of the antimicrobial potential of medicinal plants from the Ivory Coast. Phytother Res. 2002; 16:497-502.
Milner JA. New insights into mechanism of action of antioxidants. New Engl J Med. 2000; 234:196-202.
Rathee S and Kamboj A. Optimization and development of antidiabetic phytosomes by the Bpx-Behnken design. J Liposome Res. 2018; 28(2):161-172.
Bombardelli E, Curri SB, Della LR. Complexes between phospholipids and vegetable derivatives of biological interest. Fitoter, 1999; 90(1):1-9.
Trease GE and Evans WC. Pharmacognosy. Tindall Press: London, 2000. 307-702 p.
European Pharmacopoeia. 7th edition. Strasbourg: Council of Europe, 2007.
Unites States Pharmacopoeia. Rockville: United States Pharmacopoeia Conventions, 2007.
Eloff JN. Which extractant should be used for the screening and isolation of antimicrobial components from plants? J Ethnopharmacol. 1998; 60(1):1-8.
Attama AA, Onugu CO, Nnamani PO, Adikwu MU, Nzekwe IT. The use of self-emulsifying systems in the delivery of diclofenac. Int J Pharm. 2003; 262:23-28.
Gadekar R, Singour PK, Chaurasiya PK, Pawer RS, Patil UK. A Potential of some medicinal plants as an antiulcer agent. Pharmacogn Rev. 2010; 4(8):136-146.